Related Experiment Videos
Characterization of growth-inhibitory activities associated with an alpha-macroglobulin of mice
Abstract:
An alpha-macroglobulin (AMG) of similar size and proteinase-binding activity as those of human, alpha 2-macroglobulin was purified to homogeneity from mouse plasma. Even after additional purification steps, AMG still retains a growth-inhibitory activity and a more complex subunit structure than does human alpha 2-macroglobulin. AMG can inhibit the DNA synthesis of all types of murine tumor cells tested in vitro. This activity is cytostatic, dose dependent, and unaffected by the serum concentration in culture. Because this inhibitory activity is resistant to heat, pH 3, and methylamine, it is apparently unrelated to the proteinase-binding activity which is labile to all these treatments. Furthermore, in contrast to the proteinase-binding activity, the inhibitory activity can be partially removed from AMG by acid dialysis. Gel filtration of the dialysate yields two fractions (Mr 12,000 and 1,000 to 5,000) which potently inhibit murine tumor cells but stimulate both the B- and T-lymphocyte reactivities to mitogens in vitro. The growth-inhibitory activities in these fractions are resistant to digestions by chymotrypsin, RNase, and DNase. We conclude from this study that AMG does not inhibit tumor growth by virtue of its proteinase-binding activity; it may inhibit tumor cells via the small biomediators it carries.
Insights
Mouse alpha-macroglobulin (AMG) inhibits tumor cell growth through small biomediators, not proteinase binding. These biomediators also stimulate lymphocyte activity, suggesting a complex role in immune response and cancer therapy.
Area of Science:
- Biochemistry
- Immunology
- Molecular Biology
Background:
- Alpha-macroglobulin (AMG) is a protein found in mouse plasma with similar size and proteinase-binding activity to human alpha 2-macroglobulin.
- AMG exhibits growth-inhibitory activity against murine tumor cells in vitro, independent of serum concentration.
- The inhibitory activity of AMG is distinct from its proteinase-binding function, showing different stability profiles.
Purpose of the Study:
- To purify and characterize mouse alpha-macroglobulin (AMG).
- To investigate the mechanism of AMG's tumor growth inhibition.
- To identify the components responsible for AMG's biological activities.
Main Methods:
- Purification of AMG from mouse plasma to homogeneity.
- In vitro assays to assess inhibition of tumor cell DNA synthesis.
- Treatment of AMG with heat, pH 3, methylamine, and acid dialysis to differentiate activities.
- Gel filtration to isolate fractions responsible for inhibitory activity.
- Enzymatic digestion (chymotrypsin, RNase, DNase) to characterize inhibitory fractions.
- In vitro assays to assess effects on B- and T-lymphocyte reactivity.
Main Results:
- Purified AMG retained growth-inhibitory activity against murine tumor cells.
- The inhibitory activity was cytostatic, dose-dependent, and unaffected by serum.
- Inhibitory activity was resistant to heat, pH 3, and methylamine, unlike proteinase-binding activity.
- Acid dialysis partially removed inhibitory activity, yielding fractions (Mr 12,000 and 1,000-5,000) that inhibited tumor cells.
- These fractions also stimulated B- and T-lymphocyte reactivity to mitogens.
- The inhibitory activity of these fractions was resistant to chymotrypsin, RNase, and DNase.
Conclusions:
- Mouse alpha-macroglobulin (AMG) inhibits tumor cell growth via mechanisms independent of its proteinase-binding activity.
- Small biomediators carried by AMG are likely responsible for its tumor growth inhibitory effects.
- These biomediators also possess immunomodulatory properties, stimulating lymphocyte reactivity.